1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1/1b study of the novel immunotoxin MT-3724 in relapsed/refractory non-Hodgkin's B-cell lymphoma (NHL)
    Meeting Abstract

    Hamlin, P. A.; Diefenbach, C. S.; Valacer, D. J.; Higgins, J.; Fanale, M. A.
    Blood (2015)

    Fulltext@MSK | Save
  • The RIG-I agonist 3pRNA synergizes with checkpoint blockade in cancer immunotherapy
    Meeting Abstract

    Heidegger, S.; Kreppel, D.; Bscheider, M.; Wintges, A.; Bek, S.; Schmickl, M.; Ruland, J.; Peschel, C.; van den Brink, M.; Haas, T.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma
    Meeting Abstract

    Duvic, M.; Horwitz, S. M.; Kim, Y. H.; Zinzani, P. L.; Bhat, G.; Sharma, P.; Yancik, S.
    Blood (2015)

    Fulltext@MSK | Save
  • The long PD-1 receptor binding kinetics of nivolumab may increase efficacy of subsequent therapy in relapsed and refractory multiple myeloma patients
    Meeting Abstract

    Funt, S. A.; Page, D. B.; Cattry, D.; Lendvai, N.; Hassoun, H.; Landgren, O.; Borrello, I. M.; Lesokhin, A. M.
    Blood (2015)

    Fulltext@MSK | Save
  • Targeted sequencing reveals a relationship between mutational burden and clinical phenotype in MPNs
    Meeting Abstract

    Getta, B.; Rapaport, F.; Devlin, S.; Zhao, C.; Knapp, K. M.; Patel, M.; Mohanty, A.; Van den Brink, M.; Levine, R. L.; Arcila, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Cytogenetics in hairy cell leukemia at diagnosis and relapse: The rate of therapy-related myeloid malignancies is low
    Meeting Abstract

    Getta, B.; Abdel-Wahab, O.; Park, J. H.; Tallman, M. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Clinical and correlative results of a phase 1 study of cerdulatinib (PRT062070) a dual SYK/JAK inhibitor in patients with relapsed/refractory B cell malignancies
    Meeting Abstract

    Hamlin, P. A.; Flinn, I.; Wagner-Johnston, N.; Burger, J. A.; Michelson, G.; Pandey, A.; Birrell, M.; Coffey, G. P.; Leeds, J. M.; Curnutte, J. T.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Analysis of myelodysplastic syndrome stem cells at single cell resolution during DNA methyltransferase inhibitor therapy
    Journal Article

    Chung, S. S.; Vijay, P.; Stern, D. L.; O'Sullivan, D.; Klimek, V. M.; Mason, C.; Park, C. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • Phase I multicenter trial of brentuximab vedotin for steroid refractory acute graft-vs-host disease (GVHD)
    Meeting Abstract

    Chen, Y. B.; Li, S.; Konkel, S.; Loiselle, C.; Efebera, Y. A.; Devine, S. M.; El-Jawahri, A.; McAfee, S. L.; Soiffer, R. J.; Ritz, J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Five-year survival data demonstrating durable responses from a pivotal phase 2 study of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma
    Meeting Abstract

    Chen, R.; Gopal, A. K.; Smith, S. E.; Ansell, S.; Rosenblatt, J. D.; Savage, K. J.; Connors, J. M.; Engert, A.; Larsen, E. K.; Huebner, D.; more...
    Blood (2015)

    Fulltext@MSK | Save